Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.
READY... SET... GO ... internal medicine residency reform for the 21st century.
Targeted Therapies in Non-small-Cell Lung Cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted Therapies in Non-small-Cell Lung Cancer.
Targeted Therapies in Non-small-Cell Lung Cancer. Cancer Treat Res. 2019; 178:3-43.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Mutation
Precision Medicine
authors with profiles
Ravi Salgia